SCHEMBL4284409

SCHEMBL4284409

CCC/C=[C]/CC=C(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SQLE Q14534 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16741884 0.86 TSHR (0.32)
SCHEMBL6400896 0.71
SCHEMBL386523 0.71
SCHEMBL386522 0.71
SCHEMBL10880422 0.70
SCHEMBL72617 0.70
SCHEMBL4870237 0.69
SCHEMBL4870242 0.69
SCHEMBL1401893 0.68 FFAR1 (0.31)
SCHEMBL17111146 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009149496-A1 TREATMENT OF DIABETES AND COMPLICATIONS THEREOF AND RELATED DISORDERS CENTRAL NORTHERN ADELAIDE HEALTH SERVICE (AU) 2009-12-17 WO disclosed